Peripheral Vascular Devices Market Trends 2024–2031: Drug-Eluting Stents, Balloons, And Advanced Technologies

Peripheral vascular devices are medical tools used to diagnose and treat diseases of blood vessels outside the heart and brain. These devices are critical in managing peripheral artery disease, deep vein thrombosis, and chronic venous disorders. Between 2024 and 2031, innovation in drug eluting stents, drug coated balloons, and minimally invasive technologies is reshaping the market landscape.

The peripheral vascular devices market is expected to grow from US$ 12.5 billion in 2023 to US$ 18.5 billion by 2031, registering a CAGR of 5.7% during the forecast period. This growth reflects increasing prevalence of vascular conditions, expanding geriatric populations, and continuous advancements in endovascular treatment options.

Rising Adoption of Drug-Eluting Stents

Drug eluting stents remain a dominant trend in the peripheral vascular devices market. These stents release therapeutic agents that help reduce the risk of restenosis and improve long term patency of treated vessels. Compared with bare metal stents, drug eluting stents offer improved clinical outcomes in complex peripheral artery disease cases.

Manufacturers are enhancing stent flexibility, radial strength, and drug coating efficiency to improve deliverability and durability. Clinical evidence supporting these innovations continues to encourage adoption among vascular specialists and interventional cardiologists.

Why are drug eluting stents a key trend in the peripheral vascular devices market
Drug eluting stents improve long term patency by releasing therapeutic agents that reduce restenosis risk, leading to better patient outcomes compared to traditional stents.

Growing Use of Drug Coated Balloons

Drug coated balloons are emerging as a preferred solution for certain peripheral interventions. These devices deliver anti proliferative drugs directly to the vessel wall during angioplasty without leaving behind permanent implants. This approach helps preserve vessel structure and prevent restenosis, particularly in small vessel disease and in-stent restenosis cases.

Advancements in balloon coating technology and drug transfer efficiency are improving procedural success and patient outcomes. As physicians increasingly adopt vessel preservation strategies, drug coated balloons are expected to witness steady growth.

Download the sample PDF: https://www.theinsightpartners.com/sample/TIPRE00002776

Advanced Technologies Enhancing Treatment Outcomes

The market is also benefiting from innovation in atherectomy systems, chronic total occlusion devices, and advanced guidewire technologies. Atherectomy devices enable precise removal of plaque, including calcified lesions, which is essential for improving angioplasty and stent placement outcomes.

Improved imaging compatibility and catheter design are enhancing procedural accuracy. Guidewires with enhanced trackability and torque responsiveness allow physicians to navigate complex vessel anatomies with greater control and safety. 

What are the main advanced technologies shaping the peripheral vascular devices market through 2031
Drug coated balloons, atherectomy systems, chronic total occlusion devices, and enhanced guidewire technologies are major trends driving innovation and clinical adoption.

Market Drivers

Increasing Prevalence of Peripheral Vascular Diseases 
Peripheral artery disease incidence is rising due to aging populations and lifestyle related risk factors such as smoking, obesity, and diabetes.

Shift Toward Minimally Invasive Procedures 
Endovascular interventions are preferred due to shorter recovery times, reduced hospital stays, and lower complication rates.

Continuous Device Innovation 
Advancements in drug delivery systems and minimally invasive technologies support clinical effectiveness and broader adoption.

Market Opportunities

Expansion of Outpatient and Ambulatory Care Settings
Increasing use of peripheral vascular devices in outpatient facilities expands procedural access and lowers healthcare costs. 

Emerging Market Penetration
Improving healthcare infrastructure in Asia Pacific, Middle East, and South and Central America is driving future adoption.

Next Generation Drug Technologies
Enhanced drug formulations and coating technologies offer differentiation and improved clinical results.

Regional Analysis

North America holds a leading share of the peripheral vascular devices market due to advanced healthcare infrastructure, strong reimbursement frameworks, and early adoption of innovative technologies. Europe follows with steady growth supported by aging populations and rising government healthcare expenditure. Asia Pacific is expected to experience the fastest growth from 2024 to 2031, driven by expanding access to vascular care, rising disease awareness, and increasing procedural volumes. The Middle East and Africa and South and Central America continue to show steady growth as investments in interventional healthcare increase.

Key Market Players

• Abbott
• Medtronic
• Boston Scientific Corporation
• Teleflex Incorporated
• Cook Medical LLC
• Terumo Corporation
• B. Braun Melsungen AG
• BD
• Edwards Lifesciences Corporation
• Cardinal Health Inc

Future Outlook

From 2024 to 2031, the peripheral vascular devices market is expected to evolve with greater adoption of drug eluting stents, growth in drug coated balloon usage, and continued innovation in minimally invasive technologies. Manufacturers that emphasize clinical evidence, strong distribution networks, and physician education programs will be well positioned to capture market share as demand for advanced vascular treatments expands.

Related URL  

Intraocular Lens Market Forecast & Growth Analysis 2033
https://www.theinsightpartners.com/reports/intraocular-lens-market

Chromatography Resin Market Size & Emerging Trends 2033 
https://www.theinsightpartners.com/reports/chromatography-resin-market